An open-label, multicentre, expanded access study of oral AMN107 in adult patients with Imatnib (Glivec/Gleevec)-resistant or -intolerant chronic myeloid leukaemia in blast crisis, accelerated phase or chronic phase.

Project Details

Short titleAn open-label, multicentre, expanded access study of oral AMN107 in adult patients with Imatnib (Glivec/Gleevec)-resistant or -intolerant chronic myeloid leukaemia in blast crisis, accelerated phase or chronic phase.
StatusFinished
Effective start/end date1/01/0731/03/11

Funding

  • Queen Elizabeth Hospital Birmingham
  • Queen Elizabeth Hospital Birmingham